Our sponsors

Bronze sponsors

Nutricia Souvenaid Danone

Building on 125 years of research, innovation and care, Nutricia pioneers medical nutrition that helps enable life-changing and life-saving health outcomes, so that people can live their life to its fullest.

Nutricia supports healthy growth and development in early life and plays its part addressing some of the world’s biggest health challenges from birth through to old age. The Nutricia portfolio includes a wide range of nutritional solutions for pre-term birth, faltering growth, food allergy, rare metabolic diseases, age-related conditions and chronic disease, such as frailty, cancer, stroke and early Alzheimer’s disease.

As part of Danone, Nutricia embraces the company’s “One Planet. One Health” frame of action reflecting that the health of people and the health of the planet are interconnected and therefore seeks to protect and nourish both.

Souvenaid, launched in 2013 in Australia, is a medical drink formulated to nutritionally support memory function in patients with early Alzheimer’s Disease when taken daily for at least 6 months. Over time, Alzheimer’s disease causes a loss of synapses or connections in the brain. Souvenaid contains a unique combination of nutrients formulated to support the growth of brain connections. Backed by 20 years of research, Souvenaid is proven to slow memory and cognitive decline by 60% in an early stage of Alzheimer’s disease known as mild cognitive impairment when taken daily for 3 years.

STADA

STADA Australia is a speciality prescription pharmaceutical and consumer healthcare company.

Part of a global group, STADA Arzneimittel AG, the company sells its products in approximately 120 countries worldwide.

Since 2016, STADA has provided prescription products in Australia and New Zealand, for both chronic and serious medical conditions, with a particular focus on the treatment of Parkinson’s disease. The STADA Nurse Advisor Service has supported this work by partnering with all relevant healthcare professionals, providing a high-quality service for patients and their families.

Building on this success, STADA Australia is currently expanding into new therapeutic areas with a clear purpose of caring for people‘s health as a trusted partner.

Lunch Symposium sponsor

Novo Nordisk

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease.